Search

everythinglearnresearchcommunity

for

Search:↓

Higher platelet counts and activators in PRP improve hair density and thickness in treating hair loss.

Biotin deficiency is not a major cause of Telogen Effluvium hair loss.

The convention discussed various skin conditions and treatments, and highlighted the importance of vaccinations for patients on immune-altering medications.

Sertraline, an antidepressant, may rarely cause hair loss.

Exosome treatment safely increases hair density in male patients with androgenetic alopecia.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Sertraline, an antidepressant, may cause hair loss in rare cases.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

Some drugs can cause skin reactions, which may improve when the drug is stopped, and rapid diagnosis and stopping the drug is crucial.

Stress can worsen skin conditions and affect mental health, so doctors should include stress management in skin treatment.

The document concludes that anticonvulsants like phenytoin may cause skin reactions by affecting tryptophan metabolism and suggests researching vitamin levels in patients with drug reactions.

Sertraline can cause hair loss, which stops after stopping the drug.

Antibiotics often cause skin reactions, making them a major health concern.

The document describes a way to measure biotin in blood to prevent wrong test results in hormone level testing.

The book provides an overview of new trends and techniques in cosmetic dermatology.

Different hair diseases affect people during childbearing years, with treatments ranging from medication to psychological support.

Some skin conditions look like acne but are caused by drugs, and they usually get better when the drug is stopped.

Minoxidil 2% effectively treats female hair loss, promoting growth and density.

ADSC-CE treatment safely increases hair density and thickness in androgenetic alopecia patients.

Carbamazepine can cause hair loss, which may reverse when the medication is stopped.

Higher DKK-1 levels found in hair loss patients; L-ascorbic acid 2-phosphate, L-threonate, and ginsenoside F2 may help promote hair growth.

Carbamazepine caused hair loss and skin eruptions in a woman, which improved after stopping the medication.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

Hair loss lowers quality of life, causing embarrassment, frustration, and sexual rejection.

The document concludes that doctors should carefully consider off-label drug use in dermatology and always inform patients, while more research is needed on the safety and effectiveness of such practices.

Hair and scalp pain is more common and severe in breast cancer patients on chemotherapy than those on tamoxifen.

A teenager lost hair due to fluoxetine and sertraline, but it grew back after stopping these drugs and switching to a different one.

Dutasteride and finasteride have similar risk for osteoporosis and fractures in older men.

The document says that common skin conditions in adult women can be treated effectively, with acne being the most common and early-detected melanoma having a high survival rate.

Quetiapine may cause hair loss.